Peijia Medical (HKG:9996) subsidiary Achieva Medical entered into a distribution agreement with B. Braun Medical for the mainland China distribution of the SeQuent Please CIS paclitaxel drug-coated intracranial balloon dilatation catheter, according to a Monday Hong Kong bourse filing.
The product is designed to treat intracranial vascular diseases and to deliver paclitaxel precisely to diseased blood vessel walls during balloon dilatation to reduce the risk of restenosis.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.